Blood serum concentrations of kynurenic acid in patients diagnosed with recurrent depressive disorder, depression in bipolar disorder, and schizoaffective disorder treated with electroconvulsive therapy

被引:10
|
作者
Olajossy, Marcin [1 ]
Olajossy, Bartosz [2 ]
Wnuk, Sebastian [2 ]
Potembska, Emilia [3 ]
Urbanska, Ewa [2 ]
机构
[1] Uniwersytetu Med Lublinie, Klin Psychiat & Rehabil Psychiat 2, Lublin, Poland
[2] Pracownia Farmakol Komorkowej & Mol, Katedra & Zaklad Farmakol Doswiadczalnej & Klin, Lublin, Poland
[3] Uniwersytet Med Lublinie, Zaklad Pielegniarstwa Psychiat, Lublin, Poland
关键词
kynurenic acid; depression; electroconvulsive therapy; CEREBROSPINAL-FLUID; HIV-1-INFECTED PATIENTS; MAJOR DEPRESSION; ELEVATED LEVELS; MOOD DISORDERS; SCHIZOPHRENIA; BRAIN; RESISTANT; GLUTAMATE; KETAMINE;
D O I
10.12740/PP/61584
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aim: The aim of the present study was to compare blood serum kynurenic acid (KYNA) concentrations measured before ECT and after 1, 6 and 12 electroconvulsive treatment (ECT) sessions in patients with diagnoses of recurrent depressive disorder (RDD), depression in bipolar disorder (DBD) and schizoaffective disorder (SAD). Subjects and methods: The study group comprised of 50 patients with ICD-10 diagnoses of RDD, DBD and SAD. Blood serum KYNA concentrations were determined and clinical assessment was performed using the MADRS and the GAF scale. Results: Significant differences were found in blood serum KYNA levels between RDD, DBD and SAD patients treated with electroconvulsive therapy and healthy controls: 1) KYNA concentrations in DBD patients measured before ECT and after 12 ECT sessions were significantly lower than in the control group; 2) KYNA concentrations in the serum of RDD patients measured before ECT and after one and 12 ECT sessions were significantly lower than in the control group, while those measured after 6 ECT session did not differ significantly from KYNA concentrations in healthy controls; 3) higher pre-treatment blood serum concentrations of KYNA in DBD patients correlated with a higher number of illness phases and poorer general functioning before treatment; 4) significant relationships were found between higher blood serum concentrations of KYNA in RDD patients after 1 ECT session and male gender, and between higher KYNA concentrations after 6 ECT sessions and increased depression and poorer functioning before treatment in those patients. Conclusions: Results show that KYNA concentrations in all diagnostic groups were lower before ECT ( not statistically significant for the SAD group) and that there were no significant changes in those concentrations ( compared with the baseline) during ECT.
引用
收藏
页码:455 / 468
页数:14
相关论文
共 50 条
  • [1] Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder
    Pagel, Tobias
    Baldessarini, Ross J.
    Franklin, Jeremy
    Baethge, Christopher
    BIPOLAR DISORDERS, 2013, 15 (03) : 229 - 239
  • [2] ZIPRASIDONE AS ADJUNCTIVE THERAPY IN PATIENTS WITH SCHIZOAFFECTIVE OR BIPOLAR DISORDER TREATED WITH CLOZAPINE
    Benvenuti, A.
    Lattanzi, L.
    Bartolommei, N.
    Luchini, F.
    Cosentino, L.
    Mauri, M.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [3] Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder
    Nagano, Mieko
    Susuta, Yutaka
    Masui, Hideaki
    Watanabe, Yumi
    Watanabe, Koichiro
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (02) : 107 - 116
  • [4] Cognitive dysfunctions in patients diagnosed with unipolar (Major Depressive Disorder) and bipolar depression
    Suciu, B.
    Paunescu, R.
    Miclutia, I.
    EUROPEAN PSYCHIATRY, 2018, 48 : S291 - S291
  • [5] Developing therapy resistance to electroconvulsive treatment in a woman with schizoaffective disorder - Bipolar type
    VanGent, E. M.
    Stevens, A. W. M. M.
    BIPOLAR DISORDERS, 2008, 10 : 55 - 55
  • [6] Speed of antidepressant response to electroconvulsive therapy in bipolar disorder vs. major depressive disorder
    Agarkar, Smita
    Hurt, Stephen W.
    Young, Robert C.
    PSYCHIATRY RESEARCH, 2018, 265 : 355 - 359
  • [7] Factor analyses of multidimensional symptoms in a large group of patients with major depressive disorder, bipolar disorder, schizoaffective disorder and schizophrenia
    Stein, Frederike
    Lemmer, Gunnar
    Schmitt, Simon
    Brosch, Katharina
    Meller, Tina
    Fischer, Elena
    Kraus, Cynthia
    Lenhard, Lutz
    Koehnlein, Birgit
    Murata, Harumi
    Baecker, Achim
    Mueller, Matthias
    Franz, Michael
    Foerster, Katharina
    Meinert, Susanne
    Enneking, Verena
    Koch, Katharina
    Grotegerd, Dominik
    Nagels, Arne
    Nenadic, Igor
    Dannlowski, Udo
    Kircher, Tilo
    Krug, Axel
    SCHIZOPHRENIA RESEARCH, 2020, 218 : 38 - 47
  • [8] Comparative analysis of serum glutamate and gamma-aminobutyric acid levels in patients with bipolar depressive disorder and major depression disorder
    廖继武
    China Medical Abstracts(Internal Medicine), 2020, 37 (04) : 238 - 238
  • [9] Manic-depressive illness: bipolar disorder and recurrent depression
    Shansis, Flavio
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2010, 32 (01) : 100 - 100
  • [10] LONGITUDINAL TRAJECTORY OF HALLUCINATIONS IN PATIENTS WITH SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER, BIPOLAR DISORDER WITH PSYCHOSIS, AND UNIPOLAR DEPRESSION
    Goghari, Vina
    Harrow, Martin
    Grossman, Linda S.
    Rosen, Cherise
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 15 - 15